Carbapenem-Nonsusceptible Pseudomonas aeruginosa Isolates from Intensive Care Units in the United States: a Potential Role for New β-Lactam Combination Agents

類似資料

• In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa
  著者:: Asempa, Tomefa E., 等
  出版事項: (2019)
• Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing Pseudomonas aeruginosa
  著者:: Gill, Christian M., 等
  出版事項: (2020)
• Erratum for Asempa et al., “In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa”
  著者:: Asempa, Tomefa E., 等
  出版事項: (2020)
• EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase–producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations
  著者:: Maxwell J. Lasko, 等
  出版事項: (2020-07-01)
• EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase–producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations
  著者:: Lasko, Maxwell J., 等
  出版事項: (2020)